 When the FDA updated the mifepristone label in 2016, it did so to bring the labeling in line with what was already safely happening in clinical practice all across the country and around the world based on the most current evidence. In fact, from 2000 to 2015, the FDA required more comprehensive reporting relating to mifepristone than for any other drug